Novartis Venture Fund

Basel, Switzerland · CVC · CVC

About

Novartis Venture Fund The Novartis Venture Fund was founded in 1996, making it one of the oldest pharma CVCs still operating. With $750M+ in committed capital, the fund maintains a portfolio of 40+ active investments from a total of 163 over 25+ years. Check sizes start at $100K and can reach $30-50M per company over the investment lifetime. The track record includes 24 IPOs and 62 acquisitions. Dual offices in Basel (HQ) and Cambridge, MA cover both European and US biotech ecosystems. The fund

Industries

Stage focus

SeedSeries A

Geography

USEurope

Notable investments

  • Omeros
  • Annexon
  • Icebreaker Health

Raising from Novartis Venture Fund?

I've worked with founders across the industrial stack. If Novartis Venture Fund is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.

Talk to Dan